165 related articles for article (PubMed ID: 24726284)
1. Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study.
Haddadi R; Nayebi AM; Farajniya S; Brooshghalan SE; Sharifi H
Daru; 2014 Apr; 22(1):38. PubMed ID: 24726284
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
[TBL] [Abstract][Full Text] [Related]
3. Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines.
Kheradmand A; Nayebi AM; Jorjani M; Khalifeh S; Haddadi R
Neurosci Lett; 2016 Aug; 627():7-12. PubMed ID: 27222379
[TBL] [Abstract][Full Text] [Related]
4. Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.
Haddadi R; Eyvari-Brooshghalan S; Nayebi AM; Sabahi M; Ahmadi SA
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2427-2437. PubMed ID: 32715318
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.
Haddadi R; Eyvari Brooshghalan S; Farajniya S; Mohajjel Nayebi A; Sharifi H
Adv Pharm Bull; 2015 Nov; 5(4):463-9. PubMed ID: 26819917
[TBL] [Abstract][Full Text] [Related]
6. Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats.
Haddadi R; Nayebi AM; Eyvari Brooshghalan S
Biomed Pharmacother; 2018 Aug; 104():127-136. PubMed ID: 29772432
[TBL] [Abstract][Full Text] [Related]
7. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
Baluchnejadmojarad T; Roghani M; Mafakheri M
Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
[TBL] [Abstract][Full Text] [Related]
9. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
[TBL] [Abstract][Full Text] [Related]
10. Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats.
Sharifi H; Nayebi AM; Farajnia S; Haddadi R
Drug Res (Stuttg); 2015 Aug; 65(8):393-7. PubMed ID: 24782287
[TBL] [Abstract][Full Text] [Related]
11. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.
Kumari R; Kumar JB; Luthra PM
Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406
[TBL] [Abstract][Full Text] [Related]
12. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.
Khan MM; Raza SS; Javed H; Ahmad A; Khan A; Islam F; Safhi MM; Islam F
Neurotox Res; 2012 Jul; 22(1):1-15. PubMed ID: 22194158
[TBL] [Abstract][Full Text] [Related]
13. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats.
Mansouri MT; Farbood Y; Sameri MJ; Sarkaki A; Naghizadeh B; Rafeirad M
Food Chem; 2013 Jun; 138(2-3):1028-33. PubMed ID: 23411210
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
Jin F; Wu Q; Lu YF; Gong QH; Shi JS
Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
[TBL] [Abstract][Full Text] [Related]
17. The ameliorative effect of Monascus purpureus NTU 568-fermented rice extracts on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and the rat model of Parkinson's disease.
Tseng WT; Hsu YW; Pan TM
Food Funct; 2016 Feb; 7(2):752-62. PubMed ID: 26809317
[TBL] [Abstract][Full Text] [Related]
18. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats.
Li R; Zheng N; Liang T; He Q; Xu L
Brain Res; 2013 Jun; 1517():28-35. PubMed ID: 23603411
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of silymarin on oxidative stress in rat brain.
Nencini C; Giorgi G; Micheli L
Phytomedicine; 2007 Feb; 14(2-3):129-35. PubMed ID: 16638633
[TBL] [Abstract][Full Text] [Related]
20. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M
Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]